04/20/20
RUTGERS, UNIVERSITY HOSPITAL LEAD WAY IN TREATING COVID-19 WITH CONVALESCENT PLASMA FROM RECOVERED PATIENTS
Researchers, doctors call for more blood donations from former patients to help treat critically ill
Rutgers physicians and University Hospital are leading the way in using blood plasma from patients who recovered from COVID-19 to treat new patients who are severely ill with COVID-19 infections. The clinicians and hospital are calling for more blood donations from those who have survived the deadly infection.
Although COVID-19 infections and fatalities continue to increase in New Jersey and across the United States, more than 50,000 people have recovered from the novel virus. Their blood plasma
contains antibodies that may help critically ill patients fight, and perhaps conquer, the virus.
Last Friday, Rutgers practitioners at University Hospital received the first FDA approval for this treatment in New Jersey, and have thus far treated 17 patients with convalescent plasma. FDA
approval is pending for the use of this treatment for additional patients.
The effectiveness of this treatment is not yet known, though similar treatment has been studied for Ebola and the MERS virus. Practitioners and researchers will monitor and investigate the progress of COVID-19 patients who receive this treatment.
“The use of convalescent plasma – blood plasma from individuals who have recovered from COVID-19 – presents real hope for saving lives,” said Marc Klapholz, Chair of the Department of Medicine at Rutgers New Jersey Medical School and University Hospital, and the Principal Investigator for the use of Convalescent COVID-19 plasma.
“In our battle against the COVID-19 virus, we are excited to be trialing this potential life-saving therapy in partnership with Rutgers New Jersey Medical School. This treatment plan has been
used for more than 100 years to address disease outbreaks for other conditions, and we’re optimistic that it will save lives,” said Shereef Elnahal, President and CEO of University Hospital.
People interested in donating plasma must have had a confirmed positive test for COVID-19 from a lab or health facility and be eligible to donate blood. They can reach the Rutgers and
University Hospital COVID-19 Treatment Group at 973-972-5474 or via email at covidplasma@uhnj.org.
University Hospital Ranks Highest Among New Jersey Hospitals on Forbes’ Inaugural National List of Best Healthcare Employers
Monday, October 13, 2025 – University Hospital has earned national recognition on Forbes’ inaugural list of America’s Best Employers for Healthcare Professionals, debuting 56th out of 250 employers across the country. Among all New Jersey hospitals included on the list, University Hospital ranked the highest, underscoring its reputation as both a top workplace for healthcare […]
UNIVERSITY HOSPITAL ANNOUNCES CAROLE JOHNSON AS NEW PRESIDENT AND CEO
September 30, 2025: University Hospital – New Jersey’s only public academic medical center and the only state-designated Level I Trauma Center for Northern New Jersey – today announced that Carole Johnson has been named its new President and Chief Executive Officer. The appointment, which takes effect later this year, follows an extensive nationwide search. “Carole […]
University Hospital Expands Overdose Response with Buprenorphine Induction Capabilities
September 29, 2025 – University Hospital Emergency Medical Services (UH EMS) has expanded its overdose response efforts with the official launch of buprenorphine administration on all Advanced Life Support (ALS) and Mobile Intensive Care Units (MICUs) across Newark, Orange, and East Orange. Buprenorphine is a life-saving medication for opioid use disorder that relieves withdrawal symptoms […]